Unexpected Death of a Duchenne Muscular Dystrophy Patient in an N-of-1 Trial of rAAV9-delivered CRISPR-transactivator
Preprint
Abstract
An N-of-1 trial was developed to deliver a dCas9-VP64 transgene designed to upregulate the cortical dystrophin as a custom therapy for a Duchenne muscular dystrophy (DMD) patient. After showing signs of mild cardiac dysfunction and pericardial effusion, the patient acutely decompensated and sustained cardiac arrest six-days after dosing and succumbed two-days later. Post-mortem examination revealed severe acute-respiratory distress syndrome with diffuse alveolar damage. Vector biodistribution data was obtained and revealed minimal expression of transgene in liver. There was no evidence of AAV9 antibodies nor of effector T cell reactivity. These findings demonstrate innate immune signaling with capillary leak as a form of toxicity in an advanced DMD case treated with high-dose rAAV gene therapy.Keywords
This publication has 19 references indexed in Scilit:
- In Vivo Gene Editing of Muscle Stem Cells with Adeno-Associated Viral Vectors in a Mouse Model of Duchenne Muscular DystrophyMolecular Therapy - Methods & Clinical Development, 2020
- Engineering adeno-associated virus vectors for gene therapyNature Reviews Genetics, 2020
- Micro-dystrophin Genes Bring Hope of an Effective Therapy for Duchenne Muscular DystrophyMolecular Therapy, 2019
- Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular DystrophyMolecular Therapy, 2018
- The Dystrophin Complex: Structure, Function, and Implications for Therapy2015
- CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineeringNature Biotechnology, 2013
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene ExpressionCell, 2013
- Effect of Genome Size on AAV Vector PackagingMolecular Therapy, 2010
- X-linked dilated cardiomyopathy and the dystrophin geneNeuromuscular Disorders, 1999
- Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individualsCell, 1987